Endobronchial coil therapy in severe emphysema: 6-month outcomes from a Swiss National Registry | Zendy

JeanMarc Fellrath | Zendy; Thomas Scherer | Zendy; Daniel Franzen | Zendy; Alban Lovis | Zendy; Christophe von Garnier | Zendy; Jérôme Plojoux | Zendy; Paola M. Soccal | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Endobronchial coil therapy in severe emphysema: 6-month outcomes from a Swiss National Registry

Author(s) -

JeanMarc Fellrath,

Thomas Scherer,

Daniel Franzen,

Alban Lovis,

Christophe von Garnier,

Jérôme Plojoux,

Paola M. Soccal

Publication year - 2018

Publication title -

journal of thoracic disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.682

H-Index - 60

eISSN - 2077-6624

pISSN - 2072-1439

DOI - 10.21037/jtd.2018.04.53

Subject(s) - medicine , minimal clinically important difference , interim analysis , quality of life (healthcare) , pulmonary function testing , adverse effect , physical therapy , randomized controlled trial , surgery , emergency medicine , nursing

Endobronchial coils have been demonstrated in three randomized, controlled trials to improve quality of life, exercise tolerance, and lung function in patients with severe emphysema. This therapy is CE-marked and commercially available in Switzerland. Coil treated patients are followed in a post-market Swiss registry to collect safety and effectiveness data in routine clinical practice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research